MedStrato s’appelle désormais Orbid.
Intelligence de marché

Netherlands

Intelligence de marché des dispositifs médicaux pour Netherlands. Changements réglementaires, concurrents et tendances d'achats.

Table pays dernière MAJ : 7 août 2026 (peut être en retard). Le total 7 j est recalculé en direct (ancienne valeur table : 45).

0
Signaux / 7 j
89
Score d'activité (table)
6 sept. 2026
Dernier ingest UTC

Signaux des 7 derniers jours

Tendance du marchéIngesté 6 sept. 2026

eAF Release Notes v1.25.0.0 - EMA eSubmission

Tendance du marchéIngesté 6 sept. 2026

Hemoblast - European Medicines Agency (EMA)

Tendance du marchéIngesté 5 sept. 2026

EMA Public Declaration of Interests form - European Medicines Agency (EMA)

Tendance du marchéIngesté 5 sept. 2026

EMA Public Declaration of Interests form - European Medicines Agency (EMA)

Tendance du marchéIngesté 5 sept. 2026

Qualification of novel methodologies (QoNM) for medicinal product development_Procedural Guidance for applicants - European Medicines Agency (EMA)

Tendance du marchéIngesté 5 sept. 2026

EMA Public Declaration of Interests form - European Medicines Agency (EMA)

Tendance du marchéIngesté 4 sept. 2026

Guideline on the content, management and archiving of the clinical trial master file - European Medicines Agency (EMA)

Tendance du marchéIngesté 4 sept. 2026

EMA Public Declaration of Interests form - European Medicines Agency (EMA)

Tendance du marchéIngesté 3 sept. 2026

Overview of comments on the draft guideline on quality requirements for drug-device combinations (EMA/CHMP/QWP/BWP/259165/2019) - European Medicines Agency (EMA)

Tendance du marchéIngesté 3 sept. 2026

ICH E3 Structure and content of clinical study reports - Scientific guideline - European Medicines Agency (EMA)

Tendance du marchéIngesté 3 sept. 2026

Clinical development of medicinal products intended for the treatment of pain - Scientific guideline - European Medicines Agency (EMA)

Tendance du marchéIngesté 3 sept. 2026

Clinical investigation of human normal immunoglobulin for subcutaneous and/or intramuscular administration (SCIg/IMIg) - Scientific guideline - European Medicines Agency (EMA)

Tendance du marchéIngesté 3 sept. 2026

EMA Public Declaration of Interests form - European Medicines Agency (EMA)

Tendance du marchéIngesté 2 sept. 2026

Clinical investigation of medicinal products for treatment of rheumatoid arthritis - Scientific guideline - European Medicines Agency (EMA)

Tendance du marchéIngesté 2 sept. 2026

Overview of comments received on draft guideline on the development of medicinal substances contained in drug-eluting (medicinal - European Medicines Agency (EMA)

Tendance du marchéIngesté 1 sept. 2026· Source 1 sept. 2026

Voluntary data submission pilot to advance innovative alternatives to animal testing

Tendance du marchéIngesté 31 août 2026

EMA Public Declaration of Interests form - European Medicines Agency (EMA)

Tendance du marchéIngesté 30 août 2026

Guide to manufacturers and notified bodies on the procedure for requesting advice from expert panels for orphan medical devices | European Medicines Agency - European Medicines Agency (EMA)

Prochaine étape (fabricant)

Intelligence surfaces opportunities. Tender response automation matches catalog specs, attaches multi-regime evidence, and exports the buyer template.

Réserver une démo
Tender response automationComparaison logicielsRéserver une démo

Apportez leur
tableur.

Réservez une démo. Nous exécutons le fichier qu’ils ont envoyé — quelles cellules nous écrivons, lesquelles restent vides, et pourquoi.